Kameel D. Farag - 17 Aug 2026 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Aug 2026, 17:00:01 UTC
Prior SEC filing
05 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Abizer Gaslightwala, as Attorney-in-Fact

Key filing fact

Kameel D. Farag filed Form 4 for Akari Therapeutics Plc (AKTX) on 19 Aug 2026.

Key facts

  • This page summarizes Kameel D. Farag's Form 4 filing for Akari Therapeutics Plc (AKTX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Aug 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 05 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002093620 Primary reporting owner

Farag Kameel D.

Relationship
Interim CFO
Address
C/O AKARI THERAPEUTICS PLC, 401 EAST JACKSON STREET, SUITE 3300, TAMPA
Signature
/s/ Abizer Gaslightwala, as Attorney-in-Fact
Signature date
19 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AKTX transaction

American Depositary Shares representing Ordinary Shares

Award

Transaction value
Shares
+1,728
Change %
+8%
Price
$7.52*
Shares after
23,309
Date
17 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs will vest in full on September 15, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .